Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Glycobiology/Glycomics Market - Forecast (2017-2022) - Research and Markets

Research and Markets
Posted on: 20 Nov 17

The "Glycobiology/Glycomics Market: By Product Enzymes, Instruments, Kits & Reagents, By Application, By End User - Forecast (2017- 2022)" report has been added to Research and Markets' offering.

Glycobiology can be defined as the study of the structure, function and biology of carbohydrates or glycans. Glycobiology is a small but rapidly growing field in biology, which finds it relevance to biomedicine, biotechnology and basic research. Proteomics is defined as a systematic study of proteins in biological systems, has expanded the knowledge of protein expression, modification, interaction and function. Globally increasing funding and R&D activities in glycobiology is expected to remain key growth driver for the glycobiology during the period of study.

This report identifies the global glycobiology/glycomics market size in for the year 2015-2017, and forecast of the same for year 2022. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global glycobiology/glycomics market.

Geographically North America dominated the global glycobiology/glycomics market owing to presence of global bio tech companies and pharmaceutical players and higher investment into R& activities in the region. North America was followed by Europe and Asia-Pacific as the second and third largest markets for glycobiology/glycomics. However Asia-Pacific is expected to remain the fastest growing market during the period of study driven by economic developments, increasing presence of bio tech companies and growing government funding to support new product developments are the key factors driving the growth of market in developing regions.

Companies Mentioned

  • Merck KGaA
  • Takara Bio, Inc.
  • Shimadzu Corporation
  • Bruker Corporation
  • Waters Corporation
  • New England Biolabs Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • ProZyme, Inc.
  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Glycobiology/Glycomics Market, By Products

7. Glycobiology/Glycomics Market, By Application

8. Glycobiology/Glycomics Market, By End User

9. Glycobiology/Glycomics Market, By Geography

10. Market Entropy

11. Company Profiles

12. Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 20/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.